Home/Filings/4/0001209191-21-003268
4//SEC Filing

5AM Ventures V, L.P. 4

Accession 0001209191-21-003268

CIK 0001759138other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 5:07 PM ET

Size

20.7 KB

Accession

0001209191-21-003268

Insider Transaction Report

Form 4
Period: 2021-01-08
Transactions
  • Sale

    Common Stock

    2021-01-08$13.00/sh37,411$486,343380,218 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh264,589$3,439,6572,689,045 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-12$13.00/sh74,470$968,1102,614,575 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-12$13.00/sh10,530$136,890369,688 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2021-01-12$13.00/sh74,470$968,1102,614,575 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh264,589$3,439,6572,689,045 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh37,411$486,343380,218 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-12$13.00/sh10,530$136,890369,688 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2021-01-08$13.00/sh37,411$486,343380,218 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-12$13.00/sh10,530$136,890369,688 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh264,589$3,439,6572,689,045 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-12$13.00/sh74,470$968,1102,614,575 total(indirect: See footnotes)
PARMAR KUSH
10% Owner
Transactions
  • Sale

    Common Stock

    2021-01-12$13.00/sh74,470$968,1102,614,575 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh37,411$486,343380,218 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh264,589$3,439,6572,689,045 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-12$13.00/sh10,530$136,890369,688 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2021-01-12$13.00/sh10,530$136,890369,688 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh264,589$3,439,6572,689,045 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-12$13.00/sh74,470$968,1102,614,575 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh37,411$486,343380,218 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2021-01-12$13.00/sh10,530$136,890369,688 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh264,589$3,439,6572,689,045 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh37,411$486,343380,218 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-12$13.00/sh74,470$968,1102,614,575 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2021-01-08$13.00/sh264,589$3,439,6572,689,045 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-12$13.00/sh74,470$968,1102,614,575 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-08$13.00/sh37,411$486,343380,218 total(indirect: See footnotes)
  • Sale

    Common Stock

    2021-01-12$13.00/sh10,530$136,890369,688 total(indirect: See footnotes)
Footnotes (4)
  • [F1]Shares are held directly by 5AM Ventures V, L.P. ("5AM V").
  • [F2]5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Dr. Parmar, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Preferred Stock held directly by 5AM V, except to the extent of its or his pecuniary interest therein.
  • [F3]Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities").
  • [F4]5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.

Issuer

Cabaletta Bio, Inc.

CIK 0001759138

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001674324

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:07 PM ET
Size
20.7 KB